Home

Boundless Bio, Inc. - Common Stock (BOLD)

1.2100
+0.00 (0.00%)
NASDAQ · Last Trade: Nov 11th, 5:48 AM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Boundless Bio (BOLD) Q2 R&D Drops 17%fool.com
Via The Motley Fool · August 5, 2025
BOLD Stock Earnings: Boundless Bio Beats EPS for Q2 2024investorplace.com
BOLD stock results show that Boundless Bio beat analyst estimates for earnings per share the second quarter of 2024.
Via InvestorPlace · August 12, 2024
BOLD Stock Earnings: Boundless Bio Reported Results for Q1 2024investorplace.com
Boundless Bio just reported results for the first quarter of 2024.
Via InvestorPlace · May 13, 2024
Bayer-Backed Boundless Bio Falls After IPOtalkmarkets.com
Shares of Boundless Bio fell almost 10% after raising about $100 million in the company's initial public offering. Bayer is one of the biggest investors for the therapeutics company.
Via Talk Markets · March 31, 2024